Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity (Q24202197)

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to onabotulinumtoxinA and task practice therapy: a single-blind, randomized controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

A single-blinded, randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Low-dose botulinum toxin with short-term electrical stimulation in poststroke spastic drop foot: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Rationale and design of a multicentre, double-blind, prospective, randomized, European and Canadian study: evaluating patient outcomes and costs of managing adults with post-stroke focal spasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

The effect of combined use of botulinum toxin type A and functional electric stimulation in the treatment of spastic drop foot after stroke: a preliminary investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke? A double-blind randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

A Preliminary Assessment of the Benefits of the Addition of Botulinum Toxin A to a Conventional Therapy Program on the Function of People With Longstanding Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Functional electrical stimulation combined with botulinum toxin type A to improve hand function in children with spastic hemiparesis - a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Spasticity or reversible muscle hypertonia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Use of botulinum toxin in stroke patients with severe upper limb spasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Toward a taxonomy of rehabilitation interventions: Using an inductive approach to examine the "black box" of rehabilitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Botulinum toxin for the management of muscle overactivity and spasticity after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments--introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Does reducing spasticity translate into functional benefit? An exploratory meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Measuring physical impairment and disability with the Chedoke-McMaster Stroke Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Reliability of gait speed measured by a timed walking test in patients one year after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Multidisciplinary rehabilitation for adults with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Goal attainment scaling: A general method for evaluating comprehensive community mental health programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

21 January 2018

Stroke rehabilitation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Four-fold increase in direct costs of stroke survivors with spasticity compared with stroke survivors without spasticity: the first year after the event.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Botulinum toxin for adult spasticity after stroke or non-progressive brain lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Spasticity, an impairment that is poorly defined and poorly measured

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Reliability of the Modified Tardieu Scale and the Modified Ashworth Scale in adult patients with severe brain injury: a comparison study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Physical treatment interventions for managing spasticity after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: international consensus statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Spasticity: clinical perceptions, neurological realities and meaningful measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Effectiveness of constraint-induced movement therapy on activity and participation after stroke: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

The timed "Up & Go": a test of basic functional mobility for frail elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Efficacy of botulinum toxin A in upper limb function of hemiplegic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Botulinum treatment of spasticity: why is it so difficult to show a functional benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Rehabilitation in practice: Spasticity management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Goal attainment scaling: current methodological challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Multi-disciplinary rehabilitation for acquired brain injury in adults of working age

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Prevalence of spasticity post stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Clinimetric Properties of the Motor Activity Log for the Assessment of Arm Use in Hemiparetic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

Dynamic splinting after treatment with botulinum toxin type-A: a randomized controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

7 January 2021

Short-term electrical stimulation enhances the effectiveness of Botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

7 January 2021

Applying the clinical practice improvement approach to stroke rehabilitation: methods used and baseline results

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

7 January 2021

Low-dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

7 January 2021

Intramuscular Injection of Botulinum Toxin for the Treatment of Wrist and Finger Spasticity after a Stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

7 January 2021

Relation between spasticity, weakness and contracture of the elbow flexors and upper limb activity after stroke: an observational study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

7 January 2021

Validation of a Caregiver Strain Index

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

7 January 2021

Interrater reliability of a modified Ashworth scale of muscle spasticity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

7 January 2021

Botulinum toxin a, evidence-based exercise therapy, and constraint-induced movement therapy for upper-limb hemiparesis attributable to stroke: a preliminary study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

7 January 2021

Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: effect on impairment, activity limitation, and pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

7 January 2021

Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

7 January 2021

Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

7 January 2021

The role of kinesiotaping combined with botulinum toxin to reduce plantar flexors spasticity after stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009689.PUB2

7 January 2021

10.1002/14651858.CD009689.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_22ihiftipnhnhiypqqq64vazxi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/22ihiftipnhnhiypqqq64vazxi

24 November 2022

mapped directly with Wikidata item

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

23740539

1 reference

Consolidated OpenCitations Corpus – April 2017